Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Breast Cancer | Research

Genome editing approaches with CRISPR/Cas9: the association of NOX4 expression in breast cancer patients and effectiveness evaluation of different strategies of CRISPR/Cas9 to knockout Nox4 in cancer cells

Authors: Marzieh Javadi, Hossein Sazegar, Abbas Doosti

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Background

The increasing prevalence of cancer detection necessitated practical strategies to deliver highly accurate, beneficial, and dependable processed information together with experimental results. We deleted the cancer biomarker NOX4 using three novel genetic knockout (KO) methods. Homology-directed repair (HDR), Dual allele HITI (Du-HITI) and CRISPR-excision were utilized in this study.

Methods

The predictive value of the NOX4 expression profile was assessed using a combined hazard ratio (HR) with a 95% confidence interval (CI). With a 95% confidence interval, a pooled odd ratio (OR) was used to calculate the relationship between NOX4 expression patterns and cancer metastasis. There were 1060 tumor patients in all sixteen research that made up this meta-analysis. To stop the NOX4 from being transcribed, we employed three different CRISPR/Cas9-mediated knockdown methods. The expression of RNA was assessed using RT-PCR. We employed the CCK-8 assay, colony formation assays, and the invasion transwell test for our experiments measuring cell proliferation and invasion. Using a sphere-formation test, the stemness was determined. Luciferase reporter tests were carried out to verify molecular adhesion. Utilizing RT-qPCR, MTT, and a colony formation assay, the functional effects of NOX4 genetic mutation in CRISPR-excision, CRISPR-HDR, and CRISPR du-HITI knockdown cell lines of breast cancer were verified.

Results

There were 1060 malignant tumors in the 16 studies that made up this meta-analysis. In the meta-analysis, higher NOX4 expression was linked to both a shorter overall survival rate (HR = 1.93, 95% CI 1.49–2.49, P < 0.001) and a higher percentage of lymph node metastases (OR = 3.22, 95% CI 2.18–4.29, P < 0.001). In breast carcinoma cells, it was discovered that NOX4 was overexpressed, and this increase was linked to a poor prognosis. The gain and loss-of-function assays showed enhanced NOX4 breast carcinoma cell proliferation, sphere-forming capacity, and tumor development. To activate transcription, the transcriptional factor E2F1 also attaches to the promoter region of the Nanog gene. The treatment group (NOX4 ablation) had substantially more significant levels of proapoptotic gene expression than the control group (P < 0.01). Additionally, compared to control cells, mutant cells expressed fewer antiapoptotic genes (P < 0.001). The du-HITI technique incorporated a reporter and a transcription termination marker into the two target alleles. Both donor vector preparation and cell selection were substantially simpler using this approach than with “CRISPR HDR” or “CRISPR excision.“ Furthermore, single-cell knockouts for both genotypes were created when this method was applied in the initial transfection experiment.

Conclusions

The NOX4 Knockout cell lines generated in this research may be used for additional analytical studies to reveal the entire spectrum of NOX4 activities. The du-HITI method described in this study was easy to employ and could produce homozygous individuals who were knockout for a specific protein of interest.
Appendix
Available only for authorised users
Literature
1.
go back to reference Verras GI, Tchabashvili L, Chlorogiannis DD, Mulita F, Argentou MI. Updated clinical evidence on the role of adipokines and breast cancer: a review. Cancers. 2023 Mar 3;15(5):1572. Verras GI, Tchabashvili L, Chlorogiannis DD, Mulita F, Argentou MI. Updated clinical evidence on the role of adipokines and breast cancer: a review. Cancers. 2023 Mar 3;15(5):1572.
2.
go back to reference Miricescu D, Totan A, Stanescu-Spinu II, Badoiu SC, Stefani C, Greabu M. PI3K/AKT/mTOR signaling pathway in breast cancer: from molecular landscape to clinical aspects. Int J Mol Sci. 2021;22(1):173.CrossRef Miricescu D, Totan A, Stanescu-Spinu II, Badoiu SC, Stefani C, Greabu M. PI3K/AKT/mTOR signaling pathway in breast cancer: from molecular landscape to clinical aspects. Int J Mol Sci. 2021;22(1):173.CrossRef
3.
go back to reference Hamer J, Jones E, Chan A, Tahmasebi F. Can we routinely employ the use of low-pressure Gynaecological Laparoscopy? A systematic review. Cureus. 2021;13(5). Hamer J, Jones E, Chan A, Tahmasebi F. Can we routinely employ the use of low-pressure Gynaecological Laparoscopy? A systematic review. Cureus. 2021;13(5).
4.
go back to reference Umeda M, Ikeuchi M, Ishikawa M, Ito T, Nishihama R, Kyozuka J, Torii KU, Satake A, Goshima G, Sakakibara H. Plant stem cell research is uncovering the secrets of longevity and persistent growth. Plant J. 2021;106(2):326–35.CrossRefPubMedPubMedCentral Umeda M, Ikeuchi M, Ishikawa M, Ito T, Nishihama R, Kyozuka J, Torii KU, Satake A, Goshima G, Sakakibara H. Plant stem cell research is uncovering the secrets of longevity and persistent growth. Plant J. 2021;106(2):326–35.CrossRefPubMedPubMedCentral
5.
go back to reference Valle S, Martin-Hijano L, Alcalá S, Alonso-Nocelo M, Sainz B Jr. The ever-evolving concept of the cancer stem cell in pancreatic cancer. Cancers. 2018;10(2):33.CrossRefPubMedPubMedCentral Valle S, Martin-Hijano L, Alcalá S, Alonso-Nocelo M, Sainz B Jr. The ever-evolving concept of the cancer stem cell in pancreatic cancer. Cancers. 2018;10(2):33.CrossRefPubMedPubMedCentral
6.
go back to reference Huang Y, Mo W, Ding X, Ding Y. Long non-coding RNAs in breast cancer stem cells. Med Oncol. 2023 May;13(6):177. Huang Y, Mo W, Ding X, Ding Y. Long non-coding RNAs in breast cancer stem cells. Med Oncol. 2023 May;13(6):177.
13.
go back to reference Xue L, Li J, Lin Y, Liu D, Yang Q, Jian J, Peng J. m6A transferase METTL3-induced lncRNA ABHD11‐AS1 promotes the Warburg effect of non‐small‐cell lung cancer. J Cell Physiol. 2021;236(4):2649–58.CrossRefPubMed Xue L, Li J, Lin Y, Liu D, Yang Q, Jian J, Peng J. m6A transferase METTL3-induced lncRNA ABHD11‐AS1 promotes the Warburg effect of non‐small‐cell lung cancer. J Cell Physiol. 2021;236(4):2649–58.CrossRefPubMed
14.
go back to reference Zare K, Shademan M, Ghahramani Seno MM, Dehghani H. CRISPR/Cas9 knockout strategies to ablate CCAT1 lncRNA gene in cancer cells. Biol procedures online. 2018;20(1):1–2.CrossRef Zare K, Shademan M, Ghahramani Seno MM, Dehghani H. CRISPR/Cas9 knockout strategies to ablate CCAT1 lncRNA gene in cancer cells. Biol procedures online. 2018;20(1):1–2.CrossRef
15.
go back to reference Goyal A, Myacheva K, Groß M, Klingenberg M, Duran Arqué B, Diederichs S. Challenges of CRISPR/Cas9 applications for long non-coding RNA genes. Nucleic Acids Res. 2017;45(3):e12.PubMed Goyal A, Myacheva K, Groß M, Klingenberg M, Duran Arqué B, Diederichs S. Challenges of CRISPR/Cas9 applications for long non-coding RNA genes. Nucleic Acids Res. 2017;45(3):e12.PubMed
16.
go back to reference Sun C, Li S, Zhang F, Xi Y, Wang L, Bi Y, Li D. Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of mir-377-3p-E2F3 pathway. Oncotarget. 2016;7(32):51784.CrossRefPubMedPubMedCentral Sun C, Li S, Zhang F, Xi Y, Wang L, Bi Y, Li D. Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of mir-377-3p-E2F3 pathway. Oncotarget. 2016;7(32):51784.CrossRefPubMedPubMedCentral
17.
go back to reference Bassett AR, Akhtar A, Barlow DP, Bird AP, Brockdorff N, Duboule D, Ephrussi A, Ferguson-Smith AC, Gingeras TR, Haerty W, Higgs DR. Science forum: considerations when investigating lncRNA function in vivo. elife. 2014;3:e03058.CrossRefPubMedPubMedCentral Bassett AR, Akhtar A, Barlow DP, Bird AP, Brockdorff N, Duboule D, Ephrussi A, Ferguson-Smith AC, Gingeras TR, Haerty W, Higgs DR. Science forum: considerations when investigating lncRNA function in vivo. elife. 2014;3:e03058.CrossRefPubMedPubMedCentral
19.
go back to reference Bendixen L, Jensen TI, Bak RO. CRISPR/Cas-mediated transcriptional modulation: the therapeutic promises of CRISPRa and CRISPRi. Mol Ther. 2023 Mar 24. Bendixen L, Jensen TI, Bak RO. CRISPR/Cas-mediated transcriptional modulation: the therapeutic promises of CRISPRa and CRISPRi. Mol Ther. 2023 Mar 24.
20.
go back to reference Sun CC, Li SJ, Li G, Hua RX, Zhou XH, Li DJ. Long intergenic noncoding RNA 00511 acts as an oncogene in non–small-cell lung cancer by binding to EZH2 and suppressing p57. Mol Therapy-Nucleic Acids. 2016;5:e385.CrossRef Sun CC, Li SJ, Li G, Hua RX, Zhou XH, Li DJ. Long intergenic noncoding RNA 00511 acts as an oncogene in non–small-cell lung cancer by binding to EZH2 and suppressing p57. Mol Therapy-Nucleic Acids. 2016;5:e385.CrossRef
21.
go back to reference Zhao X, Liu Y, Li Z, Zheng S, Wang Z, Li W, Bi Z, Li L, Jiang Y, Luo Y, Lin Q. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR‐29b‐3p in pancreatic ductal adenocarcinoma. J Cell Mol Med. 2018;22(1):655–67.CrossRefPubMed Zhao X, Liu Y, Li Z, Zheng S, Wang Z, Li W, Bi Z, Li L, Jiang Y, Luo Y, Lin Q. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR‐29b‐3p in pancreatic ductal adenocarcinoma. J Cell Mol Med. 2018;22(1):655–67.CrossRefPubMed
22.
go back to reference Sun CC, Li SJ, Li G, Hua RX, Zhou XH, Li DJ. Long intergenic noncoding RNA 00511 acts as an oncogene in non–small-cell lung cancer by binding to EZH2 and suppressing p57. Mol Therapy-Nucleic Acids. 2016;5:e385.CrossRef Sun CC, Li SJ, Li G, Hua RX, Zhou XH, Li DJ. Long intergenic noncoding RNA 00511 acts as an oncogene in non–small-cell lung cancer by binding to EZH2 and suppressing p57. Mol Therapy-Nucleic Acids. 2016;5:e385.CrossRef
23.
go back to reference Ding J, Yang C, Yang S. LINC 00511 interacts with miR-765 and modulates tongue squamous cell carcinoma progression by targeting LAMC 2. J Oral Pathol Med. 2018;47(5):468–76.CrossRefPubMed Ding J, Yang C, Yang S. LINC 00511 interacts with miR-765 and modulates tongue squamous cell carcinoma progression by targeting LAMC 2. J Oral Pathol Med. 2018;47(5):468–76.CrossRefPubMed
24.
go back to reference Kwon Y, Lemieux M, McTavish J, Wathen N. Identifying and removing duplicate records from systematic review searches. J Med Libr Association: JMLA. 2015 Oct;103(4):184. Kwon Y, Lemieux M, McTavish J, Wathen N. Identifying and removing duplicate records from systematic review searches. J Med Libr Association: JMLA. 2015 Oct;103(4):184.
25.
go back to reference Fan Y, Chen J. Clinicopathological significance of survivin expression in patients with cervical cancer: a systematic meta-analysis. Bioengineered. 2017;8(5):511–23.CrossRefPubMedPubMedCentral Fan Y, Chen J. Clinicopathological significance of survivin expression in patients with cervical cancer: a systematic meta-analysis. Bioengineered. 2017;8(5):511–23.CrossRefPubMedPubMedCentral
26.
go back to reference Hu Y, Zhang Y, Gao J, Lian X, Wang Y. The clinicopathological and prognostic value of CD44 expression in bladder cancer: a study based on meta-analysis and TCGA data. Bioengineered. 2020;11(1):572–81.CrossRefPubMedPubMedCentral Hu Y, Zhang Y, Gao J, Lian X, Wang Y. The clinicopathological and prognostic value of CD44 expression in bladder cancer: a study based on meta-analysis and TCGA data. Bioengineered. 2020;11(1):572–81.CrossRefPubMedPubMedCentral
27.
go back to reference Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic acids research. 2023 Jan 6;51(D1):D587-92. Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic acids research. 2023 Jan 6;51(D1):D587-92.
28.
go back to reference Hemilä H. Random-effects assumption in meta-analyses. JAMA. 2019 Jul;2(1):81. Hemilä H. Random-effects assumption in meta-analyses. JAMA. 2019 Jul;2(1):81.
30.
go back to reference Prior KK, Leisegang MS, Josipovic I, Löwe O, Shah AM, Weissmann N, Schröder K, Brandes RP. CRISPR/Cas9-mediated knockout of p22phox leads to loss of Nox1 and Nox4, but not Nox5 activity. Redox biology. 2016 Oct 1;9:287 – 95. Prior KK, Leisegang MS, Josipovic I, Löwe O, Shah AM, Weissmann N, Schröder K, Brandes RP. CRISPR/Cas9-mediated knockout of p22phox leads to loss of Nox1 and Nox4, but not Nox5 activity. Redox biology. 2016 Oct 1;9:287 – 95.
31.
go back to reference Jafari N, Kim H, Park R, Li L, Jang M, Morris AJ, Park J, Huang C. CRISPR-Cas9 mediated NOX4 knockout inhibits cell proliferation and invasion in HeLa cells. PloS one. 2017 Jan 18;12(1):e0170327. Jafari N, Kim H, Park R, Li L, Jang M, Morris AJ, Park J, Huang C. CRISPR-Cas9 mediated NOX4 knockout inhibits cell proliferation and invasion in HeLa cells. PloS one. 2017 Jan 18;12(1):e0170327.
32.
go back to reference Fabbro D, et al. Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: possible quantitative relationship. Cancer Res. 1986;46(6):2720–5.PubMed Fabbro D, et al. Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: possible quantitative relationship. Cancer Res. 1986;46(6):2720–5.PubMed
33.
go back to reference Kalhori MR, Khodayari H, Khodayari S, Vesovic M, Jackson G, Farzaei MH, Bishayee A. Regulation of long non-coding RNAs by plant secondary metabolites: a novel anticancer therapeutic approach. Cancers. 2021;13(6):1274.CrossRefPubMedPubMedCentral Kalhori MR, Khodayari H, Khodayari S, Vesovic M, Jackson G, Farzaei MH, Bishayee A. Regulation of long non-coding RNAs by plant secondary metabolites: a novel anticancer therapeutic approach. Cancers. 2021;13(6):1274.CrossRefPubMedPubMedCentral
34.
go back to reference Ding J, Cao J, Chen Z, He Z. The role of long intergenic noncoding RNA 00511 in malignant tumors: a meta-analysis, database validation and review. Bioengineered. 2020;11(1):812–23.CrossRefPubMedPubMedCentral Ding J, Cao J, Chen Z, He Z. The role of long intergenic noncoding RNA 00511 in malignant tumors: a meta-analysis, database validation and review. Bioengineered. 2020;11(1):812–23.CrossRefPubMedPubMedCentral
35.
go back to reference Lu G, Li Y, Ma Y, Lu J, Chen Y, Jiang Q, Qin Q, Zhao L, Huang Q, Luo Z, Huang S. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis. J experimental Clin cancer Res. 2018;37(1):1–1.CrossRef Lu G, Li Y, Ma Y, Lu J, Chen Y, Jiang Q, Qin Q, Zhao L, Huang Q, Luo Z, Huang S. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis. J experimental Clin cancer Res. 2018;37(1):1–1.CrossRef
36.
go back to reference Chen Z, Wu H, Zhang Z, Li G, Liu B. LINC00511 accelerated the process of gastric cancer by targeting miR-625-5p/NFIX axis. Cancer Cell Int. 2019;19(1):1–2.CrossRef Chen Z, Wu H, Zhang Z, Li G, Liu B. LINC00511 accelerated the process of gastric cancer by targeting miR-625-5p/NFIX axis. Cancer Cell Int. 2019;19(1):1–2.CrossRef
37.
go back to reference Du X, Tu Y, Liu S, Zhao P, Bao Z, Li C, Li J, Pan M, Ji J. LINC00511 contributes to glioblastoma tumorigenesis and epithelial-mesenchymal transition via LINC00511/miR‐524‐5p/YB1/ZEB1 positive feedback loop. J Cell Mol Med. 2020;24(2):1474–87.CrossRefPubMed Du X, Tu Y, Liu S, Zhao P, Bao Z, Li C, Li J, Pan M, Ji J. LINC00511 contributes to glioblastoma tumorigenesis and epithelial-mesenchymal transition via LINC00511/miR‐524‐5p/YB1/ZEB1 positive feedback loop. J Cell Mol Med. 2020;24(2):1474–87.CrossRefPubMed
38.
go back to reference Huang HG, Tang XL, Huang XS, Zhou L, Hao YG, Zheng YF. Long noncoding RNA LINC00511 promoted cell proliferation and invasion via regulating miR-124-3p/EZH2 pathway in gastric cancer. Eur Rev Med Pharmacol Sci. 2020;24(8):4232–45.PubMed Huang HG, Tang XL, Huang XS, Zhou L, Hao YG, Zheng YF. Long noncoding RNA LINC00511 promoted cell proliferation and invasion via regulating miR-124-3p/EZH2 pathway in gastric cancer. Eur Rev Med Pharmacol Sci. 2020;24(8):4232–45.PubMed
39.
go back to reference Yan L, Wu X, Liu Y, Xian W. LncRNA Linc00511 promotes osteosarcoma cell proliferation and migration through sponging miR-765. J Cell Biochem. 2019;120(5):7248–56.CrossRefPubMed Yan L, Wu X, Liu Y, Xian W. LncRNA Linc00511 promotes osteosarcoma cell proliferation and migration through sponging miR-765. J Cell Biochem. 2019;120(5):7248–56.CrossRefPubMed
40.
go back to reference Li P, Feng C, Chen H, Jiang Y, Cao F, Liu J, Liu P. Elevated CRB 3 expression suppresses breast cancer stemness by inhibiting β-catenin signalling to restore tamoxifen sensitivity. J Cell Mol Med. 2018;22(7):3423–33.CrossRefPubMedPubMedCentral Li P, Feng C, Chen H, Jiang Y, Cao F, Liu J, Liu P. Elevated CRB 3 expression suppresses breast cancer stemness by inhibiting β-catenin signalling to restore tamoxifen sensitivity. J Cell Mol Med. 2018;22(7):3423–33.CrossRefPubMedPubMedCentral
41.
go back to reference Lakota J. Fate of human mesenchymal stem cells (MSC s) in humans and rodents—Is the current paradigm obtained on rodents applicable to humans? J Cell Mol Med (Online). 2018;22(4):2523–4.CrossRef Lakota J. Fate of human mesenchymal stem cells (MSC s) in humans and rodents—Is the current paradigm obtained on rodents applicable to humans? J Cell Mol Med (Online). 2018;22(4):2523–4.CrossRef
42.
go back to reference Yang S, Dong F, Li D, Sun H, Wu B, Sun T, Wang Y, Shen P, Ji F, Zhou D. Persistent distention of colon damages interstitial cells of Cajal through Ca2+-ERK‐AP‐1‐miR‐34c‐SCF deregulation. J Cell Mol Med. 2017;21(9):1881–92.CrossRefPubMedPubMedCentral Yang S, Dong F, Li D, Sun H, Wu B, Sun T, Wang Y, Shen P, Ji F, Zhou D. Persistent distention of colon damages interstitial cells of Cajal through Ca2+-ERK‐AP‐1‐miR‐34c‐SCF deregulation. J Cell Mol Med. 2017;21(9):1881–92.CrossRefPubMedPubMedCentral
43.
go back to reference Su F, He W, Chen C, Liu M, Liu H, Xue F, Bi J, Xu D, Zhao Y, Huang J, Lin T. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with akt and E2F1. Cell Death Dis. 2018;9(2):1–7.CrossRef Su F, He W, Chen C, Liu M, Liu H, Xue F, Bi J, Xu D, Zhao Y, Huang J, Lin T. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with akt and E2F1. Cell Death Dis. 2018;9(2):1–7.CrossRef
44.
go back to reference Su F, He W, Chen C, Liu M, Liu H, Xue F, Bi J, Xu D, Zhao Y, Huang J, Lin T. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with akt and E2F1. Cell Death Dis. 2018;9(2):1–7.CrossRef Su F, He W, Chen C, Liu M, Liu H, Xue F, Bi J, Xu D, Zhao Y, Huang J, Lin T. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with akt and E2F1. Cell Death Dis. 2018;9(2):1–7.CrossRef
45.
go back to reference Fang Y, Fullwood MJ. Roles, functions, and mechanisms of long non-coding RNAs in cancer. Genom Proteom Bioinform. 2016;14(1):42–54.CrossRef Fang Y, Fullwood MJ. Roles, functions, and mechanisms of long non-coding RNAs in cancer. Genom Proteom Bioinform. 2016;14(1):42–54.CrossRef
46.
go back to reference Awwad DA. Beyond classic editing: innovative CRISPR approaches for functional studies of long non-coding RNA. Biology Methods and Protocols. 2019;4(1):bpz017.CrossRefPubMedPubMedCentral Awwad DA. Beyond classic editing: innovative CRISPR approaches for functional studies of long non-coding RNA. Biology Methods and Protocols. 2019;4(1):bpz017.CrossRefPubMedPubMedCentral
48.
go back to reference Han J, Zhang J, Chen L, Shen B, Zhou J, Hu B, Du Y, Tate PH, Huang X, Zhang W. Efficient in vivo deletion of a large imprinted lncRNA by CRISPR/Cas9. RNA Biol. 2014;11(7):829–35.CrossRefPubMedPubMedCentral Han J, Zhang J, Chen L, Shen B, Zhou J, Hu B, Du Y, Tate PH, Huang X, Zhang W. Efficient in vivo deletion of a large imprinted lncRNA by CRISPR/Cas9. RNA Biol. 2014;11(7):829–35.CrossRefPubMedPubMedCentral
49.
go back to reference Paralkar VR, Taborda CC, Huang P, Yao Y, Kossenkov AV, Prasad R, Luan J, Davies JO, Hughes JR, Hardison RC, Blobel GA. Unlinking a lncRNA from its associated cis element. Mol Cell. 2016;62(1):104–10.CrossRefPubMedPubMedCentral Paralkar VR, Taborda CC, Huang P, Yao Y, Kossenkov AV, Prasad R, Luan J, Davies JO, Hughes JR, Hardison RC, Blobel GA. Unlinking a lncRNA from its associated cis element. Mol Cell. 2016;62(1):104–10.CrossRefPubMedPubMedCentral
50.
go back to reference Yin Y, Yan P, Lu J, Song G, Zhu Y, Li Z, Zhao Y, Shen B, Huang X, Zhu H, Orkin SH. Opposing roles for the lncRNA haunt and its genomic locus in regulating HOXA gene activation during embryonic stem cell differentiation. Cell Stem Cell. 2015;16(5):504–16.CrossRefPubMed Yin Y, Yan P, Lu J, Song G, Zhu Y, Li Z, Zhao Y, Shen B, Huang X, Zhu H, Orkin SH. Opposing roles for the lncRNA haunt and its genomic locus in regulating HOXA gene activation during embryonic stem cell differentiation. Cell Stem Cell. 2015;16(5):504–16.CrossRefPubMed
51.
go back to reference Zhang E, Han L, Yin D, He X, Hong L, Si X, Qiu M, Xu T, De W, Xu L, Shu Y. H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma. Nucleic Acids Res. 2017;45(6):3086–101.CrossRefPubMed Zhang E, Han L, Yin D, He X, Hong L, Si X, Qiu M, Xu T, De W, Xu L, Shu Y. H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma. Nucleic Acids Res. 2017;45(6):3086–101.CrossRefPubMed
52.
go back to reference Piri-Gharaghie T, Doosti A, Mirzaei SA. Identification of antigenic Properties of Acinetobacter baumannii Proteins as Novel putative vaccine candidates using reverse Vaccinology Approach. Appl Biochem Biotechnol. 2022:1–23. Piri-Gharaghie T, Doosti A, Mirzaei SA. Identification of antigenic Properties of Acinetobacter baumannii Proteins as Novel putative vaccine candidates using reverse Vaccinology Approach. Appl Biochem Biotechnol. 2022:1–23.
53.
go back to reference Piri-Gharaghie T. Polycystic ovary syndrome and genetic factors influencing its development: a review article. Personalized Med J. 2021;6(23):25–9. Piri-Gharaghie T. Polycystic ovary syndrome and genetic factors influencing its development: a review article. Personalized Med J. 2021;6(23):25–9.
54.
go back to reference Azadbakht N, Doosti A, Jami MS. CRISPR/Cas9-mediated LINC00511 knockout strategies, increased apoptosis of breast cancer cells via suppressing antiapoptotic genes. Biological procedures online. 2022 Dec;24(1):1–5. Azadbakht N, Doosti A, Jami MS. CRISPR/Cas9-mediated LINC00511 knockout strategies, increased apoptosis of breast cancer cells via suppressing antiapoptotic genes. Biological procedures online. 2022 Dec;24(1):1–5.
Metadata
Title
Genome editing approaches with CRISPR/Cas9: the association of NOX4 expression in breast cancer patients and effectiveness evaluation of different strategies of CRISPR/Cas9 to knockout Nox4 in cancer cells
Authors
Marzieh Javadi
Hossein Sazegar
Abbas Doosti
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11183-9

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine